Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer||
||Other / NIH / Industry||
||45||All||18 Years and older (Adult, Senior)||NCT01557959||CCCWFU 62107
|July 2007||February 2011||February 2011||March 20, 2012||February 28, 2018||June 28, 2013||